CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Generic Drugs Market Research Report Information by Type (Simple Generics and Super Generics), by Brand (Pure Generic and Branded Generic), by Indication (Central Nervous System (CNS), Cardiovascular, Urology, Oncology, Respiratory, and Others), by Route of Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Europe, Asia-Pacific, and Rest of the World – Industry Forecast till 2032
... Administration (Oral, Topical, Parenteral, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Europe, Asia-Pacific, and Rest of the World – Industry Forecast till 2032 In 2023, ... Read More
-
Global Post Traumatic Stress Disorder Therapeutics Market - 2024-2031
... CAGR of XX% during the forecast period 2024-2031 Posttraumatic stress disorder (PTSD) is a psychological disorder that affects people who have encountered or seen traumatic events, occurrences, or conditions. It may be both emotionally and ... Read More
-
Global Rare Neurological Disease Treatment Market - 2024-2031
... of 8.6% during the forecast period 2024-2031. Rare neurological diseases, also referred to as rare neurologic disorders or orphan neurological disorders, are a range of unusual and varied conditions that impact the nervous system. Rare ... Read More
-
Chronic Pain Market, By Drug Class (Opioids, Non-steroidal anti-inflammatory drugs (NSAIDS), Anticonvulsants, Antidepressants, and Others), By Indication (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer pain, Migraine, Fibromyalgia, and Others), By Application (Musculoskeletal, Neuropathy, Oncology, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Chronic pain is defined as any pain lasting for more ... Read More
-
Intraoperative Neuromonitoring Market in Us 2024-2028
... the intraoperative neuromonitoring market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size study, by Service Type (Contract Research Organizations, Contract Development and Manufacturing Organizations), by Indication (Oncology, Neurology, Cardiology, Infectious Diseases, Others), by Therapy (Cell Therapy, Gene Therapy, RNA-based Therapies, Others), by Phases (Preclinical Services, Clinical Services, Commercial Manufacturing and Packaging) and Regional Forecasts 2022-2032
... Others), by Phases (Preclinical Services, Clinical Services, Commercial Manufacturing and Packaging) and Regional Forecasts 2022-2032 The global advanced therapeutics pharmaceutical outsourcing market is valued approximately at USD 7,592.8 million in 2023 and is anticipated to ... Read More
-
Global Healthcare Nanotechnology Market Size study, by Modality (Treatment, Diagnostics), by Indication (Clinical oncology, Infectious diseases, Clinical cardiology, Orthopedics, Neurology, Urology, Ophthalmology, Immunology, Others), by Application (Drug delivery, Regenerative medicine, Implants, Diagnostic, Imaging, Vaccines, Others) and Regional Forecasts 2022-2032
... and Regional Forecasts 2022-2032 Global Healthcare Nanotechnology Market is valued approximately at USD 194.73 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 13.15% over the forecast period ... Read More
-
Global Encephalitis Treatment Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Segment Forecasts, 2023 – 2032 Global Encephalitis Treatment Market was valued at US $20.5 Billion in 2022 and is expected to reach ~US $33 Billion by 2032, growing at a CAGR of 4.8% during the ... Read More
-
Amyotrophic Lateral Sclerosis
... by 2030, growing at a CAGR of 19.4% over the analysis period 2023-2030. The U.S. Market is Estimated at US$285.8 Million While China is Forecast to Grow at 18.4% CAGR The Amyotrophic Lateral Sclerosis market ... Read More
-
Antipsychotic Drugs
... at a CAGR of 6.7% over the analysis period 2023-2030. Second Generation Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$15.7 Billion by the ... Read More
-
Global Digital Brain Health Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Region, and Segment Forecasts, 2023 – 2032 Global Digital Brain Health market was valued at US $198.1 Billion in 2022 and is expected to reach ~US $400 Billion by 2032, growing at a CAGR of ... Read More
-
Interventional Neurology Devices
... by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Cerebral Embolization & Aneurysm Coiling Device, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and ... Read More
-
Post-traumatic Stress Disorder (PTSD) - Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Cranial Fixation and Stabilization Systems
... is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. Cranial Stabilization Systems, one of the segments analyzed in the report, is expected to record a ... Read More
-
Radiopharmaceuticals in Nuclear Medicine Market, By Product Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), By Application (Oncolog, Cardiology, Neurology, Endocrinology, Others), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Diagnostic Centers, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Radiopharmaceuticals are radioactive drugs used in nuclear medicine for both diagnostics and therapeutics purposes. These play a crucial role in medical imaging techniques ... Read More
-
Clinical Trials: Psychedelic Therapeutics
... of these trials. As the number of psychedelic therapeutic clinical trials continues to increase, a deeper understanding of these trials, such as sponsor type, location, and phase, are reviewed. Scope Non-industry sponsors outnumber industry sponsors ... Read More
-
Global Analgesics Market, By Drug Type (Opioid, Non-opioid, Compound medication), By Route of Administration (Oral, Parenteral, Transdermal, Others), By Application (Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain due to Burns , Dental/Facial, Pediatric, Others), By Pain Type (Acuteand Chronic ), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Pediatric, Others), By Pain Type (Acuteand Chronic ), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Global analgesics market growth is ... Read More
-
US Artificial Intelligence (AI) in Mental Health Market Research Report Data Analysis By Component (hardware, software solutions and services), by Disorder (Schizophrenia, Alcohol Use Disorders, Bipolar Disorder, Depression, Anxiety, and Others), by Application (Clinical Diagnosis and Treatment, Patient Engagement And Education, Remote Patient Monitoring, and Others), by Technology (Natural Language Processing (NLP), Machine Learning (ML), Deep Learning, Others), by End User (Healthcare Providers, Corporate Organizations, and Others) -Industry Forecast to 2032
... and Treatment, Patient Engagement And Education, Remote Patient Monitoring, and Others), by Technology (Natural Language Processing (NLP), Machine Learning (ML), Deep Learning, Others), by End User (Healthcare Providers, Corporate Organizations, and Others) -Industry Forecast to ... Read More
-
Global Schizophrenia Treatments Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... 2023 and is forecast to a readjusted size of USD 11340 million by 2030 with a CAGR of 1.7% during review period. Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand ... Read More
-
Advanced Therapy Medicinal Products Market [Therapy Type: Cell Therapy, Gene Therapy, and Tissue Engineering; and Indication: Oncology, Neurology, Cardiology, Dermatology, Infectious Diseases, Musculoskeletal Disorders, Orthopedics, and Others (Genetic Disorders, etc.)] - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Share, Growth, Trends, and Forecast, 2024-2034 Advanced Therapy Medicinal Products Market – Scope of Report TMR’s report on the global advanced therapy medicinal productss market studies the past as well as the current growth trends ... Read More
-
Global Thin Film Drug Manufacturing Market Size Study, by Product (Oral Thin Film, Sublingual Film, Fully Dissolving Dental/Buccal Film, Transdermal Thin Film, Others), by Disease Indication (Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Others), by Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, E-commerce), and Regional Forecasts 2022-2032
... Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, E-commerce), and Regional Forecasts 2022-2032 The Global Thin Film Drug Manufacturing Market was valued at USD 6.4 billion in 2023 and is projected to grow with a ... Read More
-
Global Central Nervous System (CNS) Stimulant Drugs Market 2024-2028
... 2023-2028, accelerating at a CAGR of 6.78% during the forecast period. The report on the central nervous system (cns) stimulant drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, ... Read More
-
Global Antidepressants Drugs Market 2024-2028
... report on the antidepressants drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Companion Diagnostics Market Market By Technology (Polymerase Chain Reaction, Immunohistochemistry, In-situ Hybridization, Next Generation Gene Sequencing, and Others), By Indication (Cancer, Neurological Diseases, Infectious Diseases, and Others), By End-user (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), Regional Outlook– Global Forecast up to 2030
... Contract Research Organizations, and Others), Regional Outlook– Global Forecast up to 2030 Therapeutic drugs are used in conjunction with a medical instrument known as a companion diagnostic to evaluate how well they function and how ... Read More
-
Global Neurofeedback Systems Market 2024-2028
... report on the neurofeedback systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
Research Assistance
